Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/197786
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Aguilera, Cinthia | - |
dc.contributor.author | Padró i Miquel, Ariadna | - |
dc.contributor.author | Esteve Garcia, Anna | - |
dc.contributor.author | Cerdà, Pau | - |
dc.contributor.author | Torres Iglesias, Raquel | - |
dc.contributor.author | Llecha, Núria | - |
dc.contributor.author | Riera Mestre, Antoni | - |
dc.date.accessioned | 2023-05-10T15:12:32Z | - |
dc.date.available | 2023-05-10T15:12:32Z | - |
dc.date.issued | 2023-03-22 | - |
dc.identifier.issn | 2073-4425 | - |
dc.identifier.uri | http://hdl.handle.net/2445/197786 | - |
dc.description.abstract | Background: Hereditary hemorrhagic telangiectasia (HHT) is a rare vascular disease inherited in an autosomal dominant manner. Disease-causing variants in endoglin (ENG) and activin A receptor type II-like 1 (ACVRL1) genes are detected in more than 90% of the patients undergoing molecular testing. The identification of variants of unknown significance is often seen as a challenge in clinical practice that makes family screening and genetic counseling difficult. Here, we show that the implementation of cDNA analysis to assess the effect of splice site variants on mRNA splicing is a powerful tool. Methods: Gene panel sequencing of genes associated with HHT and other arteriovenous malformation-related syndromes was performed. To evaluate the effect of the splice site variants, cDNA analysis of ENG and ACVRL1 genes was carried out. Results: three novel splice site variants were identified in ENG (c.68-2A > T and c.1311+4_1311+8del) and ACVLR1 (c.526-6C > G) genes correspondingly in three individuals with HHT that met ≥ 3 Curaçao criteria. All three variants led to an aberrant splicing inducing exon skipping (ENG:c.68-2A > T and ACVRL1:c.526-6C > G) or intron retention (ENG:c.1311+4_1311+8del) allowing the confirmation of the predicted effect on splicing and the reclassification from unknown significance to pathogenic/likely pathogenic of two of them. Conclusions: RNA analysis should be performed to assess and/or confirm the impact of variants on splicing. The molecular diagnosis of HHT patients is crucial to allow family screening and accurate genetic counseling. A multidisciplinary approach including clinicians and geneticists is crucial when dealing with patients with rare diseases. | - |
dc.format.extent | 12 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3390/genes14030772 | - |
dc.relation.ispartof | Genes, 2023, vol. 14, num. 3 | - |
dc.relation.uri | https://doi.org/10.3390/genes14030772 | - |
dc.rights | cc-by (c) Aguilera, Cinthia et al., 2023 | - |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
dc.source | Articles publicats en revistes (Ciències Clíniques) | - |
dc.subject.classification | RNA | - |
dc.subject.classification | Cribratge genètic | - |
dc.subject.classification | Malalties vasculars | - |
dc.subject.other | RNA | - |
dc.subject.other | Genetic screening | - |
dc.subject.other | Vascular diseases | - |
dc.title | Improving hemorrhagic hereditary telangiectasia molecular diagnosis: a referral center experience | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 733346 | - |
dc.date.updated | 2023-05-10T15:12:32Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 36981042 | - |
Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
733346.pdf | 1.3 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License